Dr. Shugang Li has ten years of experience in biotechnology drug product development, rich experience in scientific research management, good at setting up and leading biomedical research teams; he can accurately grasp the international biomedicine development rules and the latest trends, and has an in-depth study of the domestic biomedicine industry, and is familiar with domestic and international biomedicine project cooperation modes of operation; as the first person in charge of the successful presidency of multiple As the first person in charge, he has successfully presided over the development of several new drugs of biological class I.
He has been engaged in the development of biopharmaceuticals for many years, and has a high theoretical and technical level in the research and development of genetically engineered drugs, as well as a wealth of scientific research and management experience. He has published many papers in academic journals at home and abroad, and was the deputy general manager of Chongqing Dotai Pharmaceutical Co., Ltd. from August 2001 to August 2003, during which the recombinant hirudin for injection, which was a new drug of class 7, was approved for clinical trial; from September 2004 to March 2005, he was the general manager of Chongqing Magen Biomedical Co. Ltd. from September 2004 to March 2005, presided over the research of "a method of highly efficient expression of tPA and other exogenous proteins using methanol yeast system and the purification and preparation technology of its expression products" has been applied for a patent, and is now entering the stage of substantive review; April 2005 to the present day, he has been the general manager of Chongqing Keran Biomedical Research and Development Co. The project "recombinant human parathyroid hormone (rhPTH( 1-84))" received clinical approval, and at the same time, the project was supported by the Technology Innovation Fund for Small and Medium-sized Enterprises of the Ministry of Science and Technology of the People's Republic of China, Chongqing Science and Technology Tackling Plan Project, and Chongqing Major Industrialization Special Project for the development of the preliminary key technologies in 2008. He has been elected as a representative of Chongqing Municipal Association for Science and Technology Congress and Chongqing Hechuan District Science and Technology Top Talent.